OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.
The DSM investment puts biomanufacturing capacity in the spotlight. Contract biomanufacturers are adding new capacity and sponsors are marketing their excess capacity.
Related Content: